ECG vs FLR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ECG exhibits a stable financial foundation with a Piotroski F-Score of 6/9 and impressive growth metrics, including 60.2% YoY earnings growth. However, the stock is significantly overvalued, trading at $136.06—well above its Graham Number ($33.13) and Intrinsic Value ($116.53). While profitability is strong with an ROE of 38.34%, the technical trend is heavily bearish (10/100), suggesting the recent 232% one-year rally may have peaked. The valuation premium is high, and the current price exceeds the analyst target of $131.50.
Fluor Corporation exhibits severe operational distress, highlighted by a critical Piotroski F-Score of 0/9, indicating a total lack of improvement in financial health across all measured dimensions. Despite a stable balance sheet with low debt and healthy liquidity ratios, the company is suffering from negative profit and gross margins and a catastrophic recent earnings miss (Actual $-9.87 vs Est $0.36). The combination of declining revenue, massive EPS contraction, and bearish insider selling outweighs the optimistic analyst target prices.
Compare Another Pair
Related Comparisons
ECG vs FLR: Head-to-Head Comparison
This page compares Everus Construction Group, Inc. (ECG) and Fluor Corporation (FLR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.